mRNA-based influenza vaccine expands the B cell response breadth in humans.
Saved in:
| Title: | mRNA-based influenza vaccine expands the B cell response breadth in humans. |
|---|---|
| Authors: | Matz HC; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA., Yu TG; Thayer School of Engineering, Dartmouth College, Hanover, NH, USA., Dixit K; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA., Kikawa C; Department of Genome Sciences, Medical Scientist Training Program, University of Washington, Seattle, WA, USA., Zhou JQ; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA., Pena Alzua G; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA., Peyton L; Thayer School of Engineering, Dartmouth College, Hanover, NH, USA.; Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, NH, USA., Madsen A; Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Microbiology, Haukeland University Hospital, Bergen, Norway., Han F; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA., Farrell AG; Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, WA, USA., Hoelzl R; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Schmitz AJ; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA., Horvath SC; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA., Keplinger HK; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA., Strnad BS; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA., Hoegger MJ; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA., Middleton WD; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA., Klebert MK; Infectious Disease Clinical Research Unit, Washington University School of Medicine, St. Louis, MO, USA., Lin NH; Moderna, Cambridge, MA, USA., Nachbagauer R; Moderna, Cambridge, MA, USA., Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Ignaz Semmelweis Institute, Interuniversity Institute for Infection Research, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Science Outreach and Pandemic Preparedness at the Medical University of Vienna, Medical University of Vienna, Vienna, Austria., Paris R; Moderna, Cambridge, MA, USA., Bloom JD; Fred Hutch Cancer Center, Seattle, WA, USA.; Howard Hughes Medical Institute, Seattle, WA, USA., Turner JS; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA., Presti RM; Infectious Disease Clinical Research Unit, Washington University School of Medicine, St. Louis, MO, USA.; Division of Infectious Diseases, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.; Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, St. Louis, MO, USA.; The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, USA., Lee J; Thayer School of Engineering, Dartmouth College, Hanover, NH, USA. jiwonjlee@korea.ac.kr.; Department of Convergence Medicine, Korea University College of Medicine, Seoul, Republic of Korea. jiwonjlee@korea.ac.kr.; Vaccine Innovation Center, Korea University College of Medicine, Seoul, Republic of Korea. jiwonjlee@korea.ac.kr., Ellebedy AH; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA. ellebedy@wustl.edu.; Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, St. Louis, MO, USA. ellebedy@wustl.edu.; The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, USA. ellebedy@wustl.edu. |
| Source: | Nature immunology [Nat Immunol] 2026 Aug; Vol. 27 (8), pp. 1666-1677. Date of Electronic Publication: 2026 Jun 15. |
| Publication Type: | Journal Article; Observational Study |
| Journal Info: | Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
